Le Lézard
Classified in: Health, Covid-19 virus
Subjects: SVY, WOM, DEI

With Only 26% Of Pregnant People In The United States Vaccinated Against COVID-19, New Survey From Maven Clinic Sheds Light On The Reasons Why

NEW YORK, Oct. 28, 2021 /PRNewswire/ -- Maven, the largest virtual clinic for women's and family health, today released findings from a study that sheds light on why so many pregnant people are hesitant to get the COVID-19 vaccine despite recommendations from the Centers for Disease Control and Prevention (CDC).

The findings come as the rate of vaccination among pregnant people remains low, with just 26% of pregnant people in the United States receiving at least one dose of the COVID-19 vaccine, according to CDC data from October 16. A representative survey of 500 pregnant people in the United States commissioned by Maven Clinic explores what is driving the low vaccination rate among pregnant people and the most influential factors guiding vaccine decision-making.

"It is important to understand why pregnant people are particularly hesitant to get vaccinated against COVID-19, despite data showing it is one of the most important things they can do to protect themselves and their babies," said Dr. Neel Shah, Chief Medical Officer of Maven. "To improve vaccination rates we must acknowledge that for many people, there is not a single source of truth. Pregnant people need trustworthy and accurate messaging from a broad array of sources, and as providers, we need to meet people where they are by truly listening to their concerns."

Maven will be offering free appointments with its OB-GYNs and midwives to answer questions and help educate pregnant people on the benefits of the COVID-19 vaccine. Individuals who have questions about the vaccine can download the Maven app and use the code ASKMAVEN to consult with a provider. Women and families who have access to Maven through their employer or their health plan can book appointments with providers at no cost, and have the opportunity to connect with a provider who shares their identity or background. 80% of Maven providers have opted into Maven's care matching program, created to promote greater trust and understanding between doctors and patients that can ultimately lead to better health outcomes. 38% of Maven providers identify as BIPOC, 8% identify as LGBTQIA+, and providers speak more than 30 different languages.

"Always-on access to expert care is at the center of what we've built at Maven and is critical to supporting members in challenging moments like this," said Kate Ryder, founder and CEO of Maven. "Our hope is that by offering free appointments with Maven providers, more pregnant people will be able to get the compassionate, evidence-based support they need to make an informed decision about the vaccine."

Since March 2020, Maven responded to the pandemic by focusing on the needs of parents and parents-to-be through the many challenges the pandemic has presented. In the early days of the pandemic, Maven providers set extra availability to meet demand from women and families as many brick and mortar clinics suspended operations or became overwhelmed. In August 2020, Maven partnered with economist and COVID-19 School Response Dashboard creator Emily Oster to develop a free, evidence-based tool to help parents make decisions about school and child care during the pandemic. As vaccines became available earlier this year, Maven providers have hosted a series of virtual classes on the COVID-19 vaccine and pregnancy, allowing families to learn about the latest clinical guidance and get all of their questions answered.

The Maven Clinic Covid-19 Vaccine Decision-Making Survey was conducted by Wakefield Research through an online survey of a representative sample of 500 US-based pregnant people between October 16 and October 22, 2021. For more information, visit Maven's blog.

Maven is the largest virtual clinic for women's and family health, offering continuous, holistic care for fertility, pregnancy and parenting. Maven's award-winning digital programs are trusted by leading employers and health plans to reduce costs and drive better health outcomes for both parents and children. Founded in 2014 by CEO Kate Ryder, Maven has been recognized as Fast Company's #1 Most Innovative Health Company and has supported more than 10 million women and families to date. Maven has raised more than $200 million in funding from leading investors including Sequoia Capital, Oak HC/FT, Dragoneer Investment Group, and Lux Capital. To learn more about how Maven is reimagining life's most critical healthcare moment, visit us at www.mavenclinic.com/.


These press releases may also interest you

at 00:01
U.S. News & World Report today published the inaugural edition of the Best Hospitals for Maternity, which expands the U.S. News Best Hospitals rankings, ratings and data offerings. This expansion builds upon more than 32 years of guiding patients and...

6 déc 2021
Today Stride Health, the leader in portable benefits for independent workers, announced its support of the "Gig Workers' Week of Action" initiative by the Centers for Medicare & Medicaid Services (CMS) to help raise awareness among independent...

6 déc 2021
The healthcare logistics market in Canada is expected to observe substantial growth during the forecast period. The government of Canada has been investing in enhancing the logistics infrastructure across the country, which is subsequently driving...

6 déc 2021
On December 9th, children visiting Adventure Dental and Vision in Aurora will have a new friend ? Robin the Robot! Designed for children by scientists, engineers, and pediatric psychologists, Robin is the first of its kind emotionally intelligent...

6 déc 2021
Today, Akeso, Inc. (9926.HK) announced that the company will support an investigator-initiated study (IIS) to evaluate the efficacy and safety of Akeso's novel, first-in-class anti-PD-1/CTLA-4 bispecific antibody, cadonilimab, for the treatment of...

6 déc 2021
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases,...

News published on 28 october 2021 at 10:22 and distributed by: